Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05939336 · ClinicalTrials.gov registry record · NA

MOS Prebiotic Potential in Older Adults

A NA study of Healthy, sponsored by University of Florida.

Active
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT05939336 is a NA study of Healthy that is active but no longer recruiting, run by University of Florida. The registered enrollment target is 40 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05939336, a NA study of Healthy, is active but no longer recruiting, sponsored by University of Florida.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Mannooligosaccharides (MOS) derived from baker's yeast may have prebiotic properties such as improving gastrointestinal function. The aims of this study are to determine the effect of MOS on gastrointestinal function and symptoms and fecal microbiota in older adults.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Mannooligosaccharides yeast extract

Study Locations (1)

Florida

  • Food Science and Human Nutrition Department, University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2023-08-01
Est. Completion 2026-06-30
Phase NA

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT05939336

The ClinicalTrials.gov registry entry for NCT05939336 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (94% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Mannooligosaccharides yeast extract is the first listed.

NCT05939336 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05939336 about?

NCT05939336 is a clinical study titled "MOS Prebiotic Potential in Older Adults". Mannooligosaccharides (MOS) derived from baker's yeast may have prebiotic properties such as improving gastrointestinal function. The aims of this study are to determine the effect of MOS on gastrointestinal function and symptoms and fecal microbiota in older adults.

What is the current status of trial NCT05939336?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-08-01. Estimated completion is 2026-06-30.

What conditions does trial NCT05939336 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT05939336?

The interventions under investigation include: Mannooligosaccharides yeast extract (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05939336?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05939336 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.